Scientists develop new, innovative methods for characterizing proteins

Oct 11, 2010 By Barry Ray

Using a combination of high-powered computers and advanced experimental magnetic resonance data, a Florida State University biophysical chemist has developed techniques that improve the way scientists can study and predict the structure and dynamics of proteins found in the human body. His innovations could ultimately shorten the time it takes researchers to develop new, more effective drugs and better understand biomedical processes that underlie a variety of health conditions.

The new techniques “allow us to more accurately understand behavior and function at all levels, how enzymes work, and how to develop drugs that bind to certain proteins,” said Rafael Brüschweiler, the George Mathew Edgar Professor in Florida State’s Department of Chemistry and Biochemistry and associate director for biophysics at the National High Magnetic Field Laboratory.

Given that there are hundreds of thousands of different proteins found in the human body, innovations such as Brüschweiler’s that can streamline their analysis and understanding are viewed as most desirable in the scientific community.

Over the past several years, Brüschweiler and his colleagues have integrated a pair of complementary but powerful tools, both of which provide detailed information about the structure and dynamics of proteins at the atomic level. (NMR) data are first collected for a particular protein that is being analyzed. (NMR is a research tool that utilizes high magnetic fields to measure the strengths, directions and temporary fluctuations of magnetic interactions between the atoms in a protein fragment.)

Next, in a technique Brüschweiler has pioneered, high-powered computers are used to validate the NMR data in terms of their realistic representation of protein structure and dynamics, as well as to make additional predictions of those characteristics.

The computational results critically rely on the shape of the protein’s “energy landscape” — the conformational space available to that protein under physiological conditions. However, due to its complexity, improving characterizations of the energy landscape is a difficult and time-consuming undertaking. In fact, until recently, a computer simulation of a single protein that represented just a microsecond took several months. Now, with the aid of the powerful computer array at Florida State’s High Performance Computing Center, it takes Brüschweiler and his group only a fraction of the time it once did.

Working with a postdoctoral associate, Da-Wei Li, Brüschweiler has found a highly efficient way to directly use the NMR information for improving the protein potential. The basic idea is to “recycle” an existing simulation of an intact protein, using methods borrowed from statistical physics, for many trial potentials until the one is found that yields the best agreement with experiment. This leads to an increase in speed by a factor of 100,000 or more over previous methods. The approach is not only efficient but also permits the improvement of the protein potential directly on intact proteins, rather than on small fragments, as was the case in the past.

“This has opened up a new way of becoming increasingly quantitative in our computations, which is key in developing a predictive understanding of the functions of proteins,” Brüschweiler said.

“As computers continue to become ever more powerful, ‘in silico’ approaches to the understanding of proteins will play in increasingly important role. However, these approaches need to be calibrated first against quantitative experimental data, which makes the combination with NMR so powerful.”

A paper describing the research was recently published in the German publication Angewandte Chemie (Applied Chemistry), one of the world’s leading peer-reviewed chemistry journals. That paper, “NMR-Based Protein Potentials,” is available here.

“This is the culmination of a number of years of research on our part, so obviously we’re excited about the progress we have made,” Brüschweiler said. “While this is fairly basic research designed to develop a greater understanding of life at a molecular level, it opens up a range of possibilities for future advances by scientists all over the world.”

“For example, it might be possible to develop and refine new drugs that target specific proteins in a certain way,” he said. “Or to design new proteins that act as ‘molecular machines’ to perform specific functions in response to chemical stimuli.”

Brüschweiler is currently in the second year of a four-year, $608,782 grant from the National Science Foundation that is helping to fund his research.

Explore further: Protein study suggests drug side effects are inevitable

Related Stories

Broken bones and medication

Oct 05, 2010

Although one in four women over 50 develops osteoporosis, most are unaware they have the disease — something Professor Suzanne Cadarette would like to change.

Baby boomers are reinventing retirement

Oct 11, 2010

(PhysOrg.com) -- The challenges faced by recent retirees are changing how we plan for and expect to experience retirement in the future, say the academics working on a new University of Melbourne study.

Scientists trick bacteria with small molecules

Oct 07, 2010

(PhysOrg.com) -- A team of Yale University scientists has engineered the cell wall of the Staphylococcus aureus bacteria, tricking it into incorporating foreign small molecules and embedding them within the ...

Recommended for you

Protein study suggests drug side effects are inevitable

May 20, 2013

A new study of both computer-created and natural proteins suggests that the number of unique pockets – sites where small molecule pharmaceutical compounds can bind to proteins – is surprisingly small, meaning drug side ...

Attacking MRSA with metals from antibacterial clays

May 17, 2013

In the race to protect society from infectious microbes, the bugs are outrunning us. The need for new therapeutic agents is acute, given the emergence of novel pathogens as well as old foes bearing heightened antibiotic resistance.

Keeping fruit, vegetables and cut flowers fresh longer

May 15, 2013

New technology offers the promise of reducing billions of dollars of losses that occur each year from the silent, invisible killer of fruits, vegetables and cut flowers—a gas whose effects are familiar to everyone who has ...

Why don't beetles freeze in the winter?

May 14, 2013

For 37 years, Queen's University Biochemistry professor Peter Davies has been unraveling the mystery of why some organisms including insects and fish don't freeze in the winter. His research into insect antifreeze protein ...

User comments : 0

More news stories

New method for producing clean hydrogen

Duke University engineers have developed a novel method for producing clean hydrogen, which could prove essential to weaning society off of fossil fuels and their environmental implications.

Protein study suggests drug side effects are inevitable

A new study of both computer-created and natural proteins suggests that the number of unique pockets – sites where small molecule pharmaceutical compounds can bind to proteins – is surprisingly small, meaning drug side ...

Beautiful 'flowers' self-assemble in a beaker

By simply manipulating chemical gradients in a beaker of fluid, materials scientists at Harvard have found that they can control the growth behavior of crystals to create precisely tailored structures—such ...

Attacking MRSA with metals from antibacterial clays

In the race to protect society from infectious microbes, the bugs are outrunning us. The need for new therapeutic agents is acute, given the emergence of novel pathogens as well as old foes bearing heightened antibiotic resistance.

If you can remember it, you can remember it wrong

(Medical Xpress)—Native peoples in regions where cameras are uncommon sometimes react with caution when their picture is taken. The fear that something must have been stolen from them to create the photo ...

B vitamins could delay dementia

(Medical Xpress)—Despite spending billions of dollars on research and development, drug companies have been unable to come up with effective treatments for dementia and Alzheimer's Disease (AD). Now, A. ...